A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
| Image |  |
|---|---|
| Description | scientific article published on 27 December 2019 |
| Author/s |
author: Sarah Lippé Benjamin Ellezam Sébastien Perreault Serge Sultan |
| Publication date | December 27, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |